Opening speakers

Professor Louise Richardson, AAS, ACSS, FRSE, RIIA,  is Vice-Chancellor of the University of Oxford. A political scientist by training, she was previously the Principal and Vice-Chancellor of the University of St Andrews, and also spent 20 years on the faculty of Harvard University, latterly as Executive Dean of the Radcliffe Institute for Advanced Study.

Professor Richardson’s book What Terrorists Want: Understanding the Enemy, Containing the Threat, precipitated a seismic shift in approaches to the study and tackling of terrorism. She serves on a number of not-for profit boards including the Carnegie Corporation of New York and the Booker Prize Foundation.


Professor Sir Nicholas White, KCMG, OBE, FRS, FMedSci, is Professor of Tropical Medicine at Oxford and Mahidol University, Thailand, and Chairman of Wellcome’s South East Asian Research Units.

Professor Sir Nick has played a key role in ensuring the global recommendation of artemisinin-based combination therapy (ACT) as the most effective treatment for falciparum malaria. His research and advocacy have transformed the treatment approaches to prevent and cure millions of patients from malaria-endemic countries in Africa and Southeast Asia. He continues his efforts on drug resistance and the pathophysiology of severe malaria, championing the use of mass drug administration as a strategy towards malaria elimination, and the use of multiple first-line therapies. At the New Year’s Honours 2017 he was appointed a KCMG for services to tropical medicine and global health.


 Conference Speakers

Agnes Sitta Kijo is the Acting Director General, Tanzania Food and Drugs Authority (TFDA). Trained as a Pharmacist in Chennai, India, she has a MSc in Pharmaceutical Technology from Kings College, London. She has worked for 18 years in regulatory affairs and is currently Chair of the Pan African Harmonization Working Party (PAHW), of regulators aiming to improve access to safe and affordable medical devices and diagnostics in Africa though harmonized regulation.

Alice Jamieson is a Policy Officer at Wellcome. As part of the Global Policy team, she has been scoping what Wellcome could do to improve quality of medicines in low and middle income country settings. She also works on epidemic preparedness and other global health issues. Before joining Wellcome, Alice worked as a Policy Adviser on emerging technologies at the Royal Society.

Dr Céline Caillet is a pharmacist. Following her University of Toulouse PhD about drug safety in Laos, she joined IDDO as research scientist and coordinator of the Medicine Quality Scientific Group, in 2015. She is author of several articles on drug safety and she is a co-author of a review on antimalarial quality and drug resistance. She also coordinated a project to assess the performances of medicine quality screening technologies.

Daniel Bempong is the Technical Director, Global Public Health at the United States Pharmacopeia (USP). He has over 20 years work experience in pharmaceutical quality control (QC), providing technical leadership in strengthening capacity of QC laboratories around the world and working with various national medicine regulatory authorities and manufacturers on medicine quality improvement activities.

Prof Facundo M. Fernández received his PhD in Chemistry from Buenos Aires University in 1999 and joined the School of Chemistry and Biochemistry at the Georgia Institute of Technology in 2004 where he currently holds the position of Vasser-Woolley Professor in Bioanalytical Chemistry. He has published over 30 papers in the field of poor quality medicine detection, and received numerous awards, including the prestigious NSF CAREER award in 2007.

Gamal Khalaf Alla is qualified as a pharmacist from Khartoum University. He has an MSc and PhD from UK Universities. He has over 25 years working as a pharmacist in medicines supply management and regulations in Sudan. He was the first secretary general of the Medicine Regulatory Authority of Sudan. Currently, he is the Director General of the National Medical Supplies Fund.

Prof. Lutz Heide studied pharmacy in Germany. For three years he worked at the Ministry of Health of Somalia and for two years at the University of Malawi. Currently he is full Professor at the Pharmaceutical Institute of Tübingen University, Germany, teaching and researching on pharmacy in global health and on substandard and falsified medicines in developing countries.

Prof Muhammad Hamid Zaman is Howard Hughes Medical Institute Professor of Biomedical Engineering and International Health at Boston University. Prof Zaman’s current research is focused on developing systems level solutions, to improve the quality of medicines. His latest book, Bitter Pills (Oxford University Press, 2018) looks at the social, economic, political and technological barriers impeding integrated solutions.

Prof Paul Newton is an infectious disease doctor, from the University of Oxford, in the Lao-Oxford-Mahosot-Wellcome Trust Research Unit in Vientiane Laos, within the MORU Tropical Health Network. He is head of the Medicine Quality Scientific Group of the Infectious Diseases Data Observatory.

Prof Philippe Guérin is Director of the Infectious Diseases Data Observatory (IDDO). He was appointed Director of the WorldWide Antimalarial Research Network (WWARN) – the prototypic model for IDDO – in January 2009. He is Professor of Epidemiology and Global Health, and is based at the Centre for Tropical Medicine and Global Health, University of Oxford.

Dr Raffaella Ravinetto, Pharm D, PhD, is a senior researcher at the Institute of Tropical Medicine (ITM) in Antwerp, where she manages a portfolio of research, networking and advocacy on medicines in low- and middle-income countries. She is the chairperson of the ITM Institutional Review Board and of the Ethics Review Board of Médecins Sans Frontières, and a scientific advisor to QUAMED.

Rui Liu is a PhD candidate at the Department of Service Management and Service Studies, Lund University. She is affiliated to the research project about Substandard and Falsified Medicines led by Prof Susanne Lundin at Lund University. Her research interest is to understand how individuals approach and navigate marketplaces that are outside the legal framework.

Souly Phanouvong is the Director for USP’s Global Public Health Asia and based in Singapore. He has over 30 years of national, regional and international experiences in medicines policy and regulation, practical expertise and skills in key aspects of medicines quality assurance systems. He has worked in many countries and organizations in different capacities, including Laos, Hungary, Australia, Switzerland, USA and Singapore. He holds a PharmD, and two PhDs.

Prof Susanne Lundin is an ethnologist at the Department of Arts & Cultural Sciences, Lund University, Sweden, and Fellow at the Stellenbosch Institute for Advanced Study, South Africa. Her research focuses on grey zones that arise when the demand for medical treatments do not meet people’s needs, such as trade in embryos, organs and substandard and falsified medical products.

Prof Veronika J. Wirtz, MSc, PhD is an Associate Professor in the Department of Global Health at the Boston University School of Public Health, where she is also Director of the World Health Organization Collaborating Center in Pharmaceutical Policy. She is a Visiting Professor of the National Institute of Public Health (INSP), Mexico, where she was a faculty member from 2005-2012.